We are using cookies on this website. We assume your consent, as you are making use of this website. A cookie is a simple small file sent with the pages of this website and stored by your browser on the hard disk of your computer. The stored information can be resent to our servers the next time you visit the website. More information
Hide this message
Sysmex Partec Company News and Events News listing Sysmex Partec received WHO…

Sysmex Partec received WHO Prequalification for CyFlow Counter System

Sysmex Partec GmbH (President & CEO: Shinjiro Akamatsu) has received

WHO Prequalification*1 of In Vitro Diagnostics for the CyFlow Counter

System with CD4 easy count kit and CD4% easy count kit.

Sysmex Partec GmbH is based in Goerlitz, Germany, and is developer and manufacturer of flow cytometer systems for diagnostics and research & industry.

There are 36.9million people living with HIV globally, with Africa bearing the largest number of infected individuals of 25.7 million. *2  CD4 testing is playing important rolls for  HIV diagnoses and monitoring process. The CyFlow Counter System is a fully equipped compact and robust desktop flow cytometer counting results in cells/µl blood sample or percentage in three minutes without the need for reference beads.

In recent years, acquiring business in healthcare section was getting more restrictive due to high requirements established by healthcare funding organisations. WHO Prequalification is the certificate for providing high standards, quality control and reliability concerning medical supply of patients. This certificate is a necessary key for access to the Essential Healthcare market especially in resource-limited countries.

With the support of Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) Sysmex Partec GmbH managed successfully to fulfil the requirements for obtaining the WHO Prequalification. Now the CyFlow Counter System is listed on WHO website for prequalified in vitro diagnostic products concerning CD4 assays. This list “helps countries to easily make evidence-based selections when purchasing IVDs that are safe, effective and cost-efficient” (cit. WHO).   

The reliable quality management system of Sysmex Partec GmbH, required for prequalification, was audited during a several days lasting on-site inspection.  Furthermore, a product dossier with all product-relevant documents for development, production, performance specifications, labelling, trade and approval history, tests and studies as well as manufacturer and management information was prepared. As a third pillar, the WHO performed a laboratory evaluation comparing the Sysmex Partec CyFlow Counter System with another CD4 flow cytometric counting system.

References
 *1: WHO Prequalifcation(http://www.who.int/topics/prequalification/en/):
WHO Prequalifcation aims to ensure that diagnostics, medicines, vaccines and immunization-related equipment and devices for high burden diseases meet global standards of quality, safety and efficacy, in order to optimize use of health resources and improve health outcomes.
The prequalification process consists of a transparent, scientifically sound assessment, which includes dossier review, consistency testing or performance evaluation and site visits to manufacturers. This information, in conjunction with other procurement criteria, is used by UN and other procurement agencies to make purchasing decisions regarding diagnostics, medicines and/or vaccines.
*2: http://www.who.int/hiv/en/

Back to overview
Copyright © Sysmex Europe GmbH. All rights reserved.